BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 26, 2012
View Archived Issues
Scientists at Merck & Co. present novel phosphodiesterase 10A inhibitors
Read More
Pfizer patents novel acetyl-CoA carboxylase inhibitors
Read More
New data disclosed on first PI3Kalpha-specific anticancer agent to enter clinic
Read More
New candidate cancer drugs discovered at Bristol-Myers Squibb
Read More
New insulin secretagogues designed in Japan
Read More
Pathway Therapeutics discloses novel PI3K/mTOR inhibitors
Read More
Lucassin approved in Australia
Read More
Chinese study yields potential biomarker of PAH severity due to heart disease
Read More
Novel data presented on launched antiepileptic at ongoing AAN meeting
Read More
Troponin activator shows promise in patients with ALS
Read More
Astellas and Drais enter partnership for candidate ulcerative colitis drug
Read More
Compugen validates two new products in autoimmune disease models
Read More
Dainippon Sumitomo Pharma completes acquisition
Read More
FDA extends review date for Relistor sNDA
Read More
Watson Pharmaceuticals announces plan for strategic acquisition
Read More
Takeda receives complete response letter for alogliptin product NDAs
Read More
Kythera Biopharmaceuticals reports on European ATX-101 studies
Read More
Eisai reports launch of Halaven in Canada
Read More
Reimbursement allows early availability of Scenesse in Switzerland
Read More
Abbott research results in new potential analgesics
Read More
New phase III data support use of levomilnacipran for MDD
Read More
Dosing complete in phase IIb blisibimod study
Read More
New Ranbaxy combination drug for malaria launched first in India
Read More
Boston Scientific stent system set for launch in Canada
Read More
First-in-human data confirm safety of Repligen product for spinal muscular atrophy
Read More